Posterior Capsule Opacification

Overview

Posterior capsule opacification (PCO) — sometimes colloquially called "secondary cataract" — is the most common complication of modern cataract surgery, arising when lens epithelial cells (LECs) left behind after cataract extraction proliferate, migrate across the posterior capsule, and undergo changes that scatter light passing through the visual axis, causing recurrence of blurred vision after an initially successful cataract surgery.¹

Epidemiology & Risk Factors

PCO's clinical timeline has shifted substantially with changes in surgical technique and IOL design. Historically, "acute-onset" PCO occurred at high rates within weeks to months of cataract surgery; over the past one to two decades this has become relatively rare in adults, largely because square-edge IOL optic designs create a physical barrier that blocks residual LECs from migrating onto the central posterior capsule.¹ Despite this, PCO rates remain substantial by five to ten years after surgery — apparently because LECs entrapped at the periphery of the capsular bag (in the region known as the Soemmering's ring) can eventually escape this confinement and populate the visual axis over a longer time course.¹

In a population-based study using French national claims data, Nd:YAG capsulotomy (the treatment for symptomatic PCO) was performed within two years of cataract surgery in about a third of patients who eventually required it, and within the first year in roughly 10%; patients treated earlier after surgery tended to be younger and to have a more frequent history of other treated ocular disease.² A Taiwanese national-database case-control study found dry eye disease, glaucoma, uveitis, age-related macular degeneration, hyperlipidemia, and peptic ulcer disease were each associated with increased odds of developing visually significant PCO, with dry eye disease, glaucoma, AMD, and hyperlipidemia remaining significant after adjustment.³

Pathophysiology

Within hours of cataract surgery, residual LECs left on the anterior and equatorial capsule are induced to express pro-inflammatory genes, initiating a wound-healing-like response.¹ These cells then proliferate and migrate to repopulate the denuded regions of the capsular bag. Two overlapping cellular processes drive the visually significant late changes: fibrotic transformation of LECs into myofibroblast-like cells via epithelial-to-mesenchymal transition (producing wrinkled, fibrotic capsule changes), and formation of characteristic "pearl-like" clusters of swollen, opacified LECs (Elschnig pearls).¹ TGF-β signaling has been implicated as a key driver of the fibrotic pathway.¹

Clinical Presentation

Patients present with gradual, painless blurring of vision, glare, or reduced contrast sensitivity that recurs weeks to years after an initially successful cataract surgery with good visual outcome. The presentation can be mistaken by patients (and occasionally by clinicians evaluating a chart without direct exam) for a recurrence of cataract, though the native cataractous lens has already been removed — the opacity is entirely within the residual capsule and/or LEC proliferation, not the (now absent) natural lens.

Exam Findings

• Fibrotic wrinkling or "orange-peel" appearance of the posterior capsule on slit-lamp exam
• Pearl-like clusters of opacified lens epithelial cells (Elschnig pearls) visible on retroillumination
• Reduced visual acuity and contrast sensitivity, often more pronounced with retroillumination or against a bright background than on standard acuity testing alone
• A previously implanted, well-centered posterior chamber IOL visible behind the opacified capsule

Classification

PCO is broadly divided into two phenotypes, which frequently co-occur:

• Fibrotic PCO: wrinkling and opacification from epithelial-to-mesenchymal transition of residual LECs into myofibroblast-like cells
• Pearl-type (regenerative) PCO: clusters of swollen, translucent LECs (Elschnig pearls) that scatter light

PCO is also commonly described by time course:

• Acute-onset PCO: developing within weeks to months of surgery; now uncommon in adults with modern square-edge IOLs
• Late-onset PCO: developing over years, from LECs escaping peripheral capsular-bag confinement¹

Differential Diagnosis

• Residual refractive error or IOL decentration/dislocation
• Cystoid macular edema (a separate cause of delayed post-cataract-surgery vision decline)
• Corneal edema or endothelial decompensation
• Recurrent or progressive retinal/macular pathology unrelated to the prior cataract surgery
• Uveitis with anterior chamber or capsular inflammatory deposits

Management

Nd:YAG laser posterior capsulotomy is the standard, highly effective treatment: a brief outpatient laser procedure creates an opening in the central opacified posterior capsule to restore a clear visual axis. Because Nd:YAG capsulotomy is itself associated with a small risk of complications — including transiently elevated intraocular pressure, retinal detachment, and cystoid macular edema — it is generally reserved for patients with visually significant symptoms rather than performed prophylactically or purely for asymptomatic capsular changes seen on exam.

Prevention begins at the time of cataract surgery: IOL optic materials and edge designs (particularly a sharp, square posterior optic edge) reduce the rate and delay the onset of PCO by physically impeding LEC migration onto the visual axis.¹ In a systematic review and meta-analysis of high myopic eyes, use of a capsular tension ring during cataract surgery was evaluated for its effect on several secondary outcomes including PCO and Nd:YAG capsulotomy rates, in addition to its primary effects on refractive predictability and IOL centration — findings the authors describe as modest and warranting cautious interpretation given the limited evidence base.⁴

Complications

• Persistent visual symptoms (glare, reduced contrast sensitivity) if capsulotomy is delayed
• Complications of Nd:YAG capsulotomy itself: transient IOP spike, IOL pitting, cystoid macular edema, and — rarely — retinal detachment
• Rarely, IOL subluxation if capsulotomy inadvertently damages zonular support

Clinical Pearls

• PCO rates have fallen sharply for acute-onset disease with modern square-edge IOL design, but late-onset PCO remains common by 5-10 years after surgery due to LECs escaping the capsular bag periphery over time.¹
• A "recurrent cataract" complaint years after uncomplicated cataract surgery should prompt evaluation for PCO on retroillumination, not just repeat refraction.
• Comorbid ocular surface disease, glaucoma, AMD, and metabolic conditions such as hyperlipidemia have each been associated with increased odds of visually significant PCO in population-based data, though this should be read as association rather than established universal risk stratification.³

Common Pitfalls

• Assuming a return of blurred vision after cataract surgery always represents PCO without excluding other causes such as cystoid macular edema or refractive shift.
• Performing Nd:YAG capsulotomy reflexively for any visible capsular opacity rather than reserving it for visually significant symptoms, given the procedure's own small but real complication risk.
• Treating incidence/timing data from a single national claims database as universally generalizable rather than reflecting that specific healthcare system and population.²
• Overlooking that "recurrent cataract" is a misleading lay description — the native lens has already been removed, and PCO is a capsule/epithelial-cell phenomenon distinct from cataract itself.